Concepedia
Statistics
Publications
24
Citations
880
H-Index
18
Active since
1986
Affiliations
St. Jude Children's Research Hospital(Current)
University of Tennessee Health Science Center
University of Michigan
University of Tennessee at Knoxville
Marshall P. Goren is an author at St. Jude Children's Research Hospital specializing in chemotherapy, medicine, and renal disease.
Publications per year
1986–1998
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
Marshall P. Goren, Reba K. Wright, Charles B. Pratt et al. · PubMed · 1987 · 112 citations
Medicine, Oncology, Toxicology +16
Cumulative renal tubular damage associated with cisplatin nephrotoxicity
Marshall P. Goren, Reba K. Wright, Marc E. Horowitz · Cancer Chemotherapy and Pharmacology · 1986 · 94 citations
Medicine, Nephrology, Oncology +12
Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.
A A Forastiere, J. Belliveau, Marshall P. Goren et al. · PubMed · 1988 · 88 citations
Pharmacy, Oncology, Pharmacokinetics +14
Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors.
C B Pratt, Marshall P. Goren, William H. Meyer et al. · Journal of Clinical Oncology · 1990 · 68 citations
Medicine, Oncology, Pharmacology +15
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Arlene A. Forastiere, Ronald B. Natale, Bonnie J. Takasugi et al. · Journal of Clinical Oncology · 1987 · 55 citations
Medicine, Oncology, Pharmacology +16
1–5 of 24